RET E762Q Recombinant Human Active Protein Kinase
Rearranged during transfection (RET) is a transmembrane receptor protein tyrosine kinase (PTK) activated normally by forming ternary complexes with its cognate ligands and co-receptors. RET alterations by point mutations and gene fusions were found in diverse cancers. RET E762Q is a mutant of RET. RET E762Q Recombinant Human Active Protein Kinase is a recombinant RET E762Q protein that can be used to study RET E762Q-related functions[1].
Product Specifications
UNSPSC
12352211
Target
RET
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
[RETE762QRecombinantHumanActiveProteinKinase]
References & Citations
[1]Liu X, et al. RET kinase alterations in targeted cancer therapy. Cancer Drug Resist. 2020 May 11;3 (3) :472-481.
Shipping Conditions
Room temperature
Scientific Category
Enzyme
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items